Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 53, 2019 - Issue 5
Journal homepage
2,378
Views
4
CrossRef citations to date
0
Altmetric
Articles

A registry-based study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide

Mohammed AlghazaliDepartment of Urology, Skåne University Hospital, Malmö, Sweden; View further author information
,
Annica LöfgrenDepartment of Urology, Skåne University Hospital, Malmö, Sweden; View further author information
,
Leif JørgensenIQVIA Solutions a/s, Copenhagen, Denmark; View further author information
,
Maja SvenssonAstellas Pharma a/s – Nordic Operation, Kastrup, DenmarkView further author information
,
Karin FagerlundAstellas Pharma a/s – Nordic Operation, Kastrup, DenmarkView further author information
&
Anders BjartellDepartment of Urology, Skåne University Hospital, Malmö, Sweden; Correspondence[email protected]
View further author information
Pages 312-318 | Received 29 Mar 2019, Accepted 15 Aug 2019, Published online: 06 Sep 2019

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Giuseppe Fallara, Charlotte Alverbratt, Hans Garmo, Hanna Vikman, Marie Hjelm Eriksson, Ingela Franck Lissbrant & Pär Stattin. (2021) Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden. Acta Oncologica 60:12, pages 1589-1596.
Read now
Mohammed Alghazali, Annica Löfgren, Newton Cheng, Karin Fagerlund & Anders Bjartell. (2020) Update on a real-world study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide. Scandinavian Journal of Urology 54:3, pages 263-264.
Read now
Carsten Nieder, Astrid Dalhaug & Ellinor Haukland. (2020) Feasibility and efficacy of sequential systemic therapy for metastatic castration-resistant prostate cancer in a rural health care setting. Scandinavian Journal of Urology 54:2, pages 110-114.
Read now

Articles from other publishers (1)

Robert Hettle, Adela Mihai, Shona H Lang, Sophie Tatman & Stephanie L Swift. (2023) Real-world outcomes for first line next-generation hormonal agents in metastatic prostate cancer: a systematic review. Future Oncology.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.